Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study is completed in the United States. It is testing Dex-methylphenidate Extended Release for ADHD.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing Dex-methylphenidate Extended Release for ADHD.
In United StatesThis study is completed in the United States. It is testing dog Adoption for PTSD.
In United StatesThis study is completed in the United States. It is testing elpipodect for Bipolarity.
In United StatesThis study is completed in the United States. It is testing elpipodect for schizophrenia.
In United StatesThis study is completed in the United States. It is testing esketamine Nasal Spray, Administered for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing flexible Dose Brexpiprazole for PTSD.
In United StatesThis study is completed in the United States. It is testing infliximab for depression.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In United StatesThis study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.
In United StatesThis study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-61393215 for depression.
In United StatesThis study is completed in the United States. It is testing JZP150 for PTSD.
In United StatesThis study was terminated in the United States. It focuses on Bipolarity.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.